Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-188.0%
operating margin TTM
-192.76%
revenue TTM
6.95 Million
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -1.43 |
| peg ratio | 0.23 |
| price to book ratio | 0.87 |
| price to sales ratio | 2.64 |
| enterprise value multiple | -0.47 |
| price fair value | 0.87 |
profitability ratios | |
|---|---|
| gross profit margin | 78.25% |
| operating profit margin | -192.76% |
| pretax profit margin | -188.29% |
| net profit margin | -188.0% |
| return on assets | -28.55% |
| return on equity | -53.55% |
| return on capital employed | -32.42% |
liquidity ratios | |
|---|---|
| current ratio | 4.39 |
| quick ratio | 4.39 |
| cash ratio | 0.96 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 43.31 |
| days of payables outstanding | 99.44 |
| cash conversion cycle | -56.13 |
| receivables turnover | 8.43 |
| payables turnover | 3.67 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.36 |
| debt equity ratio | 0.76 |
| long term debt to capitalization | 0.43 |
| total debt to capitalization | 0.43 |
| interest coverage | -3,703.53 |
| cash flow to debt ratio | -0.39 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.36 |
| cash per share | 8.30 |
| operating cash flow per share | -2.98 |
| free cash flow operating cash flow ratio | 1.13 |
| cash flow coverage ratios | -0.39 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -7.76 |
Frequently Asked Questions
When was the last time Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) reported earnings?
Ginkgo Bioworks Holdings, Inc. (DNA) published its most recent earnings results on 06-11-2025.
What is Ginkgo Bioworks Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)'s trailing twelve months ROE is -53.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ginkgo Bioworks Holdings, Inc. (DNA) currently has a ROA of -28.55%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did DNA's net profit margin stand at?
DNA reported a profit margin of -188.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is DNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.39 in the most recent quarter. The quick ratio stood at 4.39, with a Debt/Eq ratio of 0.76.